Wisdom Bioscience, Inc., a biotechnology institution pioneering non-invasive oral crab diagnostics, coming announced nan statement of its Scientific Advisory Board (SAB) pursuing nan adjacent of an first backing round. The SAB is comprised of starring experts successful cell-free DNA (cfDNA), oncology screening, and molecular diagnostics crossed research, development, and commercialization: Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su. They will supply strategical technological and objective guidance arsenic nan institution advances its merchandise pipeline and expands its work offerings.
Giulia Kennedy, Ph.D. is nan Co-Founder and Chief Scientific Officer of PinkDx, Inc., a molecular diagnostic institution focused connected women's gynecological cancers. Prior to co-founding PinkDx, she was Chief Scientific Officer and Chief Medical Officer of Veracyte, Inc. and led nan improvement and commercialization of 8 genomic diagnostic tests that changed nan modular of diligent care.
Arnold Levine, Ph.D. has spent nan past 35 years carrying retired investigation successful nan fields of molecular oncology, genomics, tumor suppressor cistron functions, and epidemiological contributions to crab formation. Most recently, his attraction has been connected nan immune consequence to cancers, crab therapies, and prevention.
John Sninsky, Ph.D. brings heavy and wide acquisition successful nan elder guidance suites of mini and endeavor laboratory developed tests and in vitro diagnostic organizations, translating invention into reimbursed objective believe for infectious and familial diseases arsenic good arsenic oncology and coagulated organ transplantation. His exertion acquisition includes improvement and commercialization of PCR, next-generation sequencing (NGS) of nan quality genome, genome-wide relation studies and liquid biopsies.
Martin Goldberg, Ph.D. presently holds nan title of Distinguished Scientific Fellow astatine Seer, Inc. He has spent complete 30 years successful nan life sciences devices industry, spanning some research-use and diagnostic platforms crossed nan fields of genomics and proteomics. He thrives astatine nan intersection of technical, tactical and strategical challenges, and moving pinch early-stage start-up companies to thief them navigate these waters.
Professor Tin Tin Su, Ph.D. brings much than 25 years' expertise successful chemic genetics and insubstantial regeneration aft radiation damage, utilizing Drosophila and quality crab models.
Founded successful 2024, Wisdom Bioscience is focused connected changing nan scenery of oral crab screening by integrating precocious genomic technologies into regular dental care. It has developed a level for nan non-invasive discovery of oral cancer, pinch nan extremity of introducing a regular oral crab screening trial delivered done modular dental appointments. Using a elemental rima swab and NGS technology, nan trial is designed to alteration earlier discovery of oral crab successful an accessible objective setting.
The institution is backed by a distinguished group of investors, including Stephen Quake and Jay Flatley, providing beardown validation of Wisdom Bioscience's exertion and commercialized vision. Proceeds from nan financing will support continued objective validation, and preparations for commercialized motorboat later this year.
We person assembled a highly accomplished group of technological leaders whose corporate expertise will beryllium instrumental successful guiding some our merchandise improvement and semipermanent strategy,"
Aditya Rajagopal, Ph.D., Co-Founder and Chairman of nan Board, Wisdom Bioscience
Hayden Jeffreys, Co-Founder and Chief Executive Officer, Wisdom Bioscience, added: "The statement of our SAB, alongside nan support of specified respected investors represents a beardown endorsement of our imagination and our ambition to toggle shape oral crab diagnostics and screening, peculiarly arsenic we advancement towards our adjacent backing round."
English (US) ·
Indonesian (ID) ·